GALLIVAC IBD

Land: Irland

Språk: engelska

Källa: HPRA (Health Products Regulatory Authority)

Köp det nu

Ladda ner Produktens egenskaper (SPC)
16-07-2020
Ladda ner DSU (DSU)
14-12-2023

Aktiva substanser:

Infectious bursal disease virus, attenuated strain S706

Tillgänglig från:

Boehringer Ingelheim Vetmedica GmbH

ATC-kod:

QI01AD09

INN (International namn):

Infectious bursal disease virus, attenuated strain S706

Dos:

.

Läkemedelsform:

Lyophilisate for oculonasal suspension/use in drinking water

Receptbelagda typ:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapiområde:

avian infectious bursal disease virus (gumboro disease)

Bemyndigande status:

Authorised

Tillstånd datum:

2006-12-21

Produktens egenskaper

                                Health Products Regulatory Authority
15 July 2020
CRN009VN8
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
GALLIVAC IBD
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose contains:
Active ingredient:
Infectious Bursal Disease virus, attenuated strain S706, at least 10
4.0
CCID
50
Excipient:
qs 1 dose
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lyophilisate for suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (broilers, future layers and broiler breeders).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of chickens to protect against mortality and to
reduce lesions associated with Infectious Bursal (Gumboro)
Disease. Immunity has been demonstrated 2 weeks after the first
administration and has been shown under field conditions to
persistthroughout the rearing period.
4.3 CONTRAINDICATIONS
Do not vaccinate unhealthy birds.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Due to the spread of the vaccine virus, it is recommended to separate
vaccinated and unvaccinated birds.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
During spray administration, the eyes must be protected by safety
goggles and the nose and mouth by a dust mask. A helmet
with filtered air circulation may be used instead of goggles and a
mask.Care should be taken during reconstitution of the
vaccine and drinking water application. Hands should be washed and
disinfected after vaccinating.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Laboratory studies have shown that when the vaccine virus was
experimentally passed from bird to bird, damage to the bursa
increased. This was detected by histological examination of the
bursae. However, this is not considered to result in an
immunosuppressive effect.
Health Products Regulatory Authority
15 July 2020
CRN009VN8
Page 2 of 4
4.7 USE DURING PREGNANCY, LACTATION OR L
                                
                                Läs hela dokumentet
                                
                            

Visa dokumenthistorik